🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06983444
Recruiting Not applicable

Bipolar Resection vs Enucleation of Prostate

NCT06983444 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-06-01
Last updated
2025-05-21

Condition(s) studied

Benign Prostatic Hyperplasia (BPH) Requiring Surgical ResectionBenign Prostatic Hyperplasia With Outflow ObstructionBenign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract SymptomsBenign Prostatic Hyperplasia With Lower Urinary Tract Symptoms

Investigational drug(s) / intervention(s)

TURPTUEP

TURP: Using bipolar loop diathermy via cystoscopy, excess prostate tissue is resected piecemeal to remove obstruction to the prostatic urethra due to BPH.

TUEP: Using bipolar enucleation loop diathermy via cystoscopy, to anatomically enucleate prostate.

Study summary

The aim of this study is to evaluate efficacy and safety of transurethral resection of the prostate and bipolar enucleation of the prostate.

Eligibility

Sex
MALE
Min age
50 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patients with lower urinary tract symptoms (LUTS) due to BPH. 2. Patients with international prostate score system (IPSS) more than 8. 3. Patients with maximal urinary flow rate (Qmax) less than 10ml/second. 4. Patients with Prostatic volume (60 - 100 gm). 5. Patient with indication for surgical intervention. 6. Patient age (50-80 years old) Exclusion Criteria: 1. Prostatic cancer. 2. Bladder cancer. 3. Urethral stricture. 4. Neurogenic bladder.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Medicine South Valley University Qina Qena Governorate Recruiting

More South Valley University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06983444 on ClinicalTrials.gov ↗ ← All trials in Egypt